Jiaxin Pi

917 citations
34 papers · 716 indexed · h-index 17
Topics
Nanoparticle-Based Drug Delivery (6 papers)Flavonoids in Medical Research (5 papers)Traditional Chinese Medicine Analysis (4 papers)
Partner nations
ChinaEthiopia

In The Last Decade

Jiaxin Pi

32 papers receiving 710 citations

Peers

Jiaxin Pi
Comparison fields: 5 of 90
  • Molecular Biology 262
  • Pharmaceutical Science 222
  • Biomaterials 104
  • Pharmacology 96
  • Dermatology 88
Replace Pan Guo with:
Pan Guo China
Xiaoqing Miao China
Naveen Chella India
Khaled Shalaby Saudi Arabia
Omar Awad Alsaidan Saudi Arabia
Vieri Piazzini Italy
Cong Yan China
Linhua Wu China
Poonam Kushwaha India
Jiaxin Pi relative to Pan Guo China Pan Guo's profile →
Citations per field
00.5×3.3×
Pan Guo · 1×
Citations per year

Countries citing papers authored by Jiaxin Pi

Since Specialization
Citations

This map shows the geographic impact of Jiaxin Pi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxin Pi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxin Pi more than expected).

Fields of papers citing papers by Jiaxin Pi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxin Pi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxin Pi. The network helps show where Jiaxin Pi may publish in the future.

Co-authorship network of co-authors of Jiaxin Pi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxin Pi. A scholar is included among the top collaborators of Jiaxin Pi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxin Pi. Jiaxin Pi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 14
4 14
5 24
6 9
7 34
8 30
9 81
10 21
11 41
12 71
13 2
14 24
15 14
16 18
17
Tissue distribution study of salvianolic acid B long-circulating liposomes in mice by UPLC-MS/MS determination.
3
18 106
19
[Study on prescription of self-microemulsifying drug delivery system of mangiferin phospholipid complex].
7
20 15

About Jiaxin Pi

Jiaxin Pi is a scholar working on Pharmaceutical Science, Pharmacology and Complementary and alternative medicine, having authored 34 papers that have together received 716 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Flavonoids in Medical Research (5 papers) and Traditional Chinese Medicine Analysis (4 papers). The work is most often cited by research in Pharmaceutical Science (222 citations), Pharmacology (96 citations) and Dermatology (88 citations). Jiaxin Pi has collaborated with scholars based in China and Ethiopia. Frequent co-authors include Zhidong Liu, Dongli Qi, Pan Guo, Dereje Kebebe, Yumei Wu, Zhe Ma, Nan Li, Peng Lü, Shuya Wang and Bing Zhang. Their work appears in journals such as Molecules, International Journal of Pharmaceutics and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026